cystic-fibrosis

Documents about cystic-fibrosis

• Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.#852812ClinicalTrials.gov
• Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)#136371ClinicalTrials.gov
• Behavioral & Nutritional Treatment to Help CF Preschoolers Grow#442038ClinicalTrials.gov
• Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)#444812ClinicalTrials.gov
• Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period#640428ClinicalTrials.gov
• Gut Imaging for Function & Transit in Cystic Fibrosis Study 2#805675ClinicalTrials.gov
• Pharmacokinetics of Linezolid in Children With Cystic Fibrosis#865857ClinicalTrials.gov
• DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis#874228ClinicalTrials.gov
• Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX )#901582ClinicalTrials.gov
• Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis#905023ClinicalTrials.gov
• EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis#896195ClinicalTrials.gov
• Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients#18649ClinicalTrials.gov
• Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis#67947ClinicalTrials.gov
• Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis#238161ClinicalTrials.gov
• Effect of a Nursing Program for Patients With Cystic Fibrosis on Disease Management#813801ClinicalTrials.gov
• Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis#835146ClinicalTrials.gov
• Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis#875485ClinicalTrials.gov
• Gaming Console Home-Based Exercise for Adults With Cystic Fibrosis#877037ClinicalTrials.gov
• Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis#880511ClinicalTrials.gov
• Cholecalciferol for Vitamin D in Adult Cystic Fibrosis (CF) Patients#891888ClinicalTrials.gov
• Prevention of Cystic Fibrosis Diabetes#901159ClinicalTrials.gov
• Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis#901398ClinicalTrials.gov
• Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis#914676ClinicalTrials.gov
• A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis#915333ClinicalTrials.gov
• Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240#918663ClinicalTrials.gov
• Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes#864035ClinicalTrials.gov
• Pharmacokinetic and Pharmacodynamic Analysis of Ceftaroline in Children and Adolescents With Cystic Fibrosis#414511ClinicalTrials.gov
• Investigating the Use of a Positive Parenting Programme to Improve Treatment Adherence in Cystic Fibrosis#800975ClinicalTrials.gov
• Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis#813210ClinicalTrials.gov
• Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis#838488ClinicalTrials.gov
• Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis#852293ClinicalTrials.gov
• Clinical Impact of MI on Inhaled Antibiotic Adherence in Cystic Fibrosis#861281ClinicalTrials.gov
• Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation#862305ClinicalTrials.gov
• Use of Capnography for the Follow-up of Cystic Fibrosis Children#867892ClinicalTrials.gov
• The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis#879537ClinicalTrials.gov
• Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis#880267ClinicalTrials.gov
• Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis#880707ClinicalTrials.gov
• Anti-IL5 and Other Biotherapies in Cystic Fibrosis#896048ClinicalTrials.gov
• Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease#902213ClinicalTrials.gov
• Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease#903767ClinicalTrials.gov
• Prevalence and Impact of Depression and Anxiety in Cystic Fibrosis#913673ClinicalTrials.gov
• 6 Minute Walk Test in Cystic Fibrosis#981715ClinicalTrials.gov
• The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic Fibrosis#994295ClinicalTrials.gov
• Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis#1008771ClinicalTrials.gov
• Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients#141051ClinicalTrials.gov
• Parenting Concerns in Patients With Cystic Fibrosis (MucoPar)#827583ClinicalTrials.gov
• Study of Ataluren (PTC124™) in Cystic Fibrosis#841422ClinicalTrials.gov
• An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis#844875ClinicalTrials.gov
• A Study Evaluating the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis#851187ClinicalTrials.gov
• Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del#854886ClinicalTrials.gov